A draft guidance seeks to require broader clinical trials for diabetes drugs, in an effort to better identify potential adverse health effects before they receive FDA approval.
A new study appears to reinforce previous research linking the diabetes drug Avandia to an increased risk of heart failure and other cardiovascular problems.
A new study indicates diabetes drugs like Avandia may cause heart problems through mitochondrial toxicity, which could be preventable through the use of other medications.
Researchers warn that while Actos may prevent diabetes in some cases, users face an increased risk of bone fractures, weight gain and edema.
The FDA has removed all restrictions on the use of Avandia, years after warning that the diabetes drug could increase the risk of heart attacks.
Doctors should individualize diabetes drug treatments for patients with a high risk of heart disease, due to the varying levels of cardiovascular risk associated with certain diabetes drugs, according to…
A new report raises concerns that the FDA is revealing only a fraction of the potential conflicts of interest on its advisory boards.
A new study shows that computer modeling could link some drug side effects to certain proteins, allowing drug companies and the FDA to detect more possible adverse event risks before…
A new study suggests that taking insulin with metformin increases a diabetic's risk of heart problems and death, and highlights the confusion over diabetes drug choices.
A medical journal finds that collected data indicates that metformin cannot be used to decrease heart risk in people without diabetes.
